ESS
44
5
CI
35
2
VTR
44
4
PFE
37
4
AZO
46
3
BIIB
36
8
KR
50
5
KO
44
2
UAL
73
3
SIG
52
5
PNC
48
6
GT
43
2
CCL
68
6
ECL
54
5
XOM
33
3
VIX
41
-11
R
55
-2
M
40
3
SLG
37
6
PYPL
49
4
ESS
44
5
CI
35
2
VTR
44
4
PFE
37
4
AZO
46
3
BIIB
36
8
KR
50
5
KO
44
2
UAL
73
3
SIG
52
5
PNC
48
6
GT
43
2
CCL
68
6
ECL
54
5
XOM
33
3
VIX
41
-11
R
55
-2
M
40
3
SLG
37
6
PYPL
49
4
Financhill
Back

Allogene Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
4

ALLO
Allogene Therapeutics

Last Price:
$1.88
Seasonality Move:
0.51%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
4
Allogene Therapeutics (ALLO) is a Sell

Is Allogene Therapeutics a Buy, Sell or Hold?

  • The current Allogene Therapeutics [ALLO] share price is $1.87. The Score for ALLO is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • ALLO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALLO Stock Price Chart

What is Allogene Therapeutics's stock price today?

  • The Allogene Therapeutics share price today is $1.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

ALLO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 36.26 Sell
Chaikin Money Flow: 998415 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.98 - 2.38) Sell
Bollinger Bands (100): (2.26 - 2.86) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.71 - 15.03) Sell

ALLO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.97 Sell
20-day SMA: 2.18 Sell
50-day SMA: 2.48 Sell
200-day SMA: 2.86 Sell
8-day EMA: 1.98 Sell
20-day EMA: 2.14 Sell
50-day EMA: 2.37 Sell
200-day EMA: 2.88 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.97 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.02 Sell

Allogene Therapeutics Earnings Growth & ALLO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.07 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Allogene Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):